http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0903187-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d6eb785a13032f52d1f7f654acac96d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 2009-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_462a5bc71ff9c58b65f6e5f88fb0b2bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47d4909876588743655653943bd91601 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dc5f5052d5f8174d14b50707c42fef6 |
| publicationDate | 2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0903187-B1 |
| titleOfInvention | method for predicting the clinical response of a dengue virus infected patient during the first days after symptom onset, a method for diagnosing dengue virus infection, and a kit for determining the prognosis of the clinical response of a dengue infected patient |
| abstract | Clinical response prognostic markers of dengue virus infected patients The invention relates to a method for providing prognosis of clinical response of dengue virus infected patients conducted by analyzing the expression of a gene group as well as allelic polymorphism and protein levels encoded by them by the following methods: dna microarray, nortbern blot, pcr, quantitative pcr, western blot, elisa and flow cytometry, the use of any of the above or related methods is the basis for development of predictive clinical response kits, thus facilitating clinical management. |
| priorityDate | 2009-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.